Caverject (Pharmacia and Upjohn Company LLC)
Welcome to the PulseAid listing for the Caverject drug offered from Pharmacia and Upjohn Company LLC. This Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pharmacia and Upjohn Company LLC |
| NON-PROPRIETARY NAME: | Alprostadil |
| SUBSTANCE NAME: | ALPROSTADIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |
| ROUTE: | INTRACAVERNOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-07-06 |
| END MARKETING DATE: | 0000-00-00 |
Caverject HUMAN PRESCRIPTION DRUG Details:
| Item Description | Caverject from Pharmacia and Upjohn Company LLC |
| LABELER NAME: | Pharmacia and Upjohn Company LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20.5(ug/mL) |
| START MARKETING DATE: | 1995-07-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0009-3701_3ce01621-0e34-4f2d-8830-784de0d0bc9f |
| PRODUCT NDC: | 0009-3701 |
| APPLICATION NUMBER: | NDA020379 |
Other ALPROSTADIL Pharmaceutical Manufacturers / Labelers:
